NDC 13985-701 - MotaZol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13985-701
- Package NDCs from labels
- 13985-701-07, 13985-701-15, 13985-701-30, 13985-701-21
- Manufacturer
- MWI
- Effective date
- 2024-11-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| MotaZol - MWI | MWI | 2024-11-15 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13985-701-07 | MotaZol | 7.5 g in 1 BOTTLE, DISPENSING | SUSPENSION | 7.5 | 7 | |
| 13985-701-07 | MotaZol | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-701-15 | MotaZol | 15 g in 1 BOTTLE, DISPENSING | SUSPENSION | 15 | 7 | |
| 13985-701-15 | MotaZol | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-701-21 | MotaZol | 215 g in 1 BOTTLE, PLASTIC | SUSPENSION | 215 | 7 | |
| 13985-701-21 | MotaZol | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-701-30 | MotaZol | 1 in 1 CARTON | SUSPENSION | 1 | 7 | |
| 13985-701-30 | MotaZol | 30 g in 1 BOTTLE, DISPENSING | SUSPENSION | 30 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Clotrimazole | ACTIVE INGREDIENT | G07GZ97H65 | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Gentamicin Sulfate | ACTIVE INGREDIENT | 8X7386QRLV | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Mometasone Furoate Monohydrate | ACTIVE INGREDIENT | MTW0WEG809 | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Clotrimazole | ACTIVE MOIETY | G07GZ97H65 | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Gentamicin | ACTIVE MOIETY | T6Z9V48IKG | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 | |
| Mometasone | ACTIVE MOIETY | 8HR4QJ6DW8 | MOTAZOL (GENTAMICIN SULFATE, MOMETASONE FUROATE MONOHYDRATE, AND CLOTRIMAZOLE) SUSPENSION [MWI] | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gentamicin | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | 09cf88af-59da-f147-e063-6294a90aac99 | 2023-11-10 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Smooth Gator Fungus Eliminator | CLOTRIMAZOLE | Smooth Gator, LLC | 262b04f5-1b5d-4c67-a557-01f8b1711302 | 2023-11-10 | Warnings | G07GZ97H65 |
| Terrasil Jock Itch Treatment Maximum Strength | CLOTRIMAZOLE | Aidance Skincare & Topical Solutions, LLC | c62fbf23-5d19-44ab-9c1a-e9b803192ed0 | 2023-11-08 | Warnings | G07GZ97H65 |
| Clotrimazole | CLOTRIMAZOLE | Proficient Rx LP | 800a9dab-d287-427e-af6d-26996e0def41 | 2023-11-01 | Warnings | G07GZ97H65 |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | 0cce2238-28d3-4280-b520-ffc3067a2ffa | 2023-10-31 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| JOCK-EZE | CLOTRIMAZOLE | Bentlin Products LLC | d3ff5bfb-2e0f-4daa-84b3-4a3016ca9280 | 2023-10-30 | Warnings | G07GZ97H65 |
| TheraPlus Plus | CLOTRIMAZOLE | Zhejiang Jingwei Pharmaceutical Co., Ltd. | de75179d-1889-4823-9f39-4bebdf185d76 | 2023-10-27 | Warnings | G07GZ97H65 |
| Thera plus Antifungal Clotrimazole | CLOTRIMAZOLE | FOURSTAR GROUP USA, INC. | 1265be99-8922-4b76-bd63-19bfb42c3896 | 2023-10-26 | Warnings | G07GZ97H65 |
| Gentamicin | GENTAMICIN | Fresenius Kabi USA, LLC | be5b414e-d598-4721-80ee-5836156ad210 | 2023-10-24 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin | GENTAMICIN SULFATE | Fresenius Kabi USA, LLC | a73a5453-c091-43fd-aae2-d992152363b1 | 2023-10-20 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | 5ca32ede-b546-4b65-90d6-c69add760522 | 2023-09-28 | Warnings, Adverse reactions | G07GZ97H65 |
| Gentamicin | GENTAMICIN | Hikma Pharmaceuticals USA Inc. | 51fffac8-fb6e-4f7f-b2de-440252781a42 | 2023-09-07 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | A-S Medication Solutions | b3f69dc2-2b88-4866-baea-aa3b3ed84fb1 | 2023-05-16 | Warnings, Adverse reactions | G07GZ97H65 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | A-S Medication Solutions | 76fabcd6-4da3-49e3-85a1-ca4fac55a207 | 2023-05-08 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Medical Purchasing Solutions, LLC | a8b15217-cccb-2260-e053-2995a90a709d | 2023-05-03 | Boxed warning, Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Padagis Israel Pharmaceuticals Ltd | 4cfbe37e-11d6-46fc-b287-0561387b17b7 | 2023-01-31 | Adverse reactions | 8X7386QRLV |
| Clotrimazole | CLOTRIMAZOLE | H2-Pharma, LLC | 388f7e35-efbe-496b-a8d6-518caa22328d | 2023-01-11 | Warnings | G07GZ97H65 |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Asclemed USA, Inc. | b59e49e0-640b-43c3-ad07-711d1bb154e9 | 2022-07-19 | Warnings, Adverse reactions | 8X7386QRLV |
| Gentamicin Sulfate | GENTAMICIN SULFATE | Proficient Rx LP | 3a6677a6-def5-443e-82bc-c185d41f03b7 | 2022-06-01 | Warnings, Adverse reactions | 8X7386QRLV |
| Clotrimazole and Betamethasone Dipropionate | CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE | Proficient Rx LP | 3d235926-6f17-4aa5-be82-7f1b4357e247 | 2022-06-01 | Adverse reactions | G07GZ97H65 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.